Sustainable Pharmaceutical Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material (Paper, Glass, Metal, Plastic), By Process (Reusable Packaging, Biodegradable Packaging, Recycled Packaging), By Product Type (Bottles, Caps & Closures, Pouches & Sachets, Others), By End User (Pharma Manufacturing, Contract Packaging, Retail Pharmacy, Others), By Reg
Published Date: December - 2024 | Publisher: MIR | No of Pages: 320 | Industry: Chemicals | Format: Report available in PDF / Excel Format
View Details Buy Now 2890 Download Sample Ask for Discount Request CustomizationSustainable Pharmaceutical Packaging Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Material (Paper, Glass, Metal, Plastic), By Process (Reusable Packaging, Biodegradable Packaging, Recycled Packaging), By Product Type (Bottles, Caps & Closures, Pouches & Sachets, Others), By End User (Pharma Manufacturing, Contract Packaging, Retail Pharmacy, Others), By Reg
| Forecast Period | 2025-2029 |
| Market Size (2023) | USD 72.84 Billion |
| Market Size (2029) | USD 116.50 Billion |
| CAGR (2024-2029) | 8.22% |
| Fastest Growing Segment | Biodegradable Packaging |
| Largest Market | Europe |
Market Overview
Global Sustainable Pharmaceutical Packaging Market was valued at USD 72.84 Billion in 2023 and is anticipated to project impressive growth in the forecast period with a CAGR of 8.22% through 2029. The Sustainable Pharmaceutical Packaging Market comprises companies and solutions dedicated to developing eco-friendly packaging materials and methods for pharmaceutical products. This market segment prioritizes the reduction of environmental impact through innovative packaging designs that use renewable materials, ensure recyclability, and reduce waste. As the pharmaceutical industry continues to grow, sustainable packaging is becoming increasingly vital in addressing environmental concerns and adhering to stringent regulations regarding sustainability.
Key Market Drivers
Increasing Investment for the Development of Technology & Medicines
The growth of the pharmaceutical market has benefitted from the efforts of several nations. The industry is in charge of developing, producing, and selling medicines all over the world. More than one trillion dollars revenue are generated by the pharmaceutical sector worldwide. Many pharmaceuticals manufacturing companies like Pfizer, GlaxoSmithKline (GSK), Novartis, are determinedly spending substantial sums of money on the creation of new and improved medications.
The escalating investment in the development of technology and medicines is fueling a cycle of continuous growth and innovation within the healthcare industry. This increasing financial support stems from various sources, including government initiatives, private investments, and research grants, all aimed at advancing medical science and improving patient outcomes. As investment pours into research and development endeavors, there is a corresponding acceleration in the pace of technological advancements and pharmaceutical discoveries. These investments facilitate the exploration of cutting-edge technologies such as artificial intelligence, genomics, and precision medicine, revolutionizing diagnostics, treatment modalities, and patient care pathways. The pharmaceutical sector benefits from substantial investments directed towards drug discovery, clinical trials, and regulatory approvals, leading to the introduction of novel therapies and breakthrough medicines. Ultimately, this synergistic interplay between investment and innovation propels the healthcare industry forward, driving advancements that have the potential to transform healthcare delivery, enhance quality of life, and address unmet medical needs on a global scale.
Growing Demand from Pharmaceutical Industry
With increasing number of drugs approval by the regulatory bodies further increase the demand of packaging material by manufacturers industry as the production of drugs increases. For instance, in 2022, US Food and Drug Administration’s (FDA) Center for Drug Evaluation and Research (CDER) approved 37 novel drugs. Rising acquisitions and mergers in the pharmaceuticals industry as well as introduction of new technology with efficient and cost-effective production methods along with this growing valuable investment is also contributing to the growth of market. In Jan 2023, Sun Pharma acquired US-based Concert Pharma which helps to add a late-stage, potential best-in-class treatment for Alopecia Areata in Deuruxolitinib.
Many pharmaceutical industries have expanded outsourcing packaging-related tasks to save costs and save time. To ensure effective packaging, firms are outsourcing packaging activities to specialized and highly competent contractors rather than investing in packaging items. It is anticipated that this would rise the demand of contract manufacturing. Pharmaceutical companies also use child-resistant and senior-friendly (CRSF) recyclable packaging solution to reduce the risk of children and senior ingesting hazardous materials. In developed nations it is compulsory to use child resistant packaging for medicines such as paracetamol, aspirin, iron tablets. Therefore, high demand for sustainable pharmaceutical packaging led to the growth of Global Sustainable Pharmaceutical Packaging Market in the forecast years.
Rising Demand for Sustainable & Durable Packaging
The development and application of packaging in pharmaceutical sector that increases sustainability is referred to as sustainable pharmaceutical packaging. Reusing the package and lessening the environmental impact are made possible by strong, long-lasting packaging goods with returnable features. Sustainability packaging reduces the amount of packaging trash that ends up in landfills. End users are adopting more environmentally friendly packaging strategies to improve the reputation of their brands, as well as increased regulatory pressure on the usage of plastic packaging. For instance, according to the 2022 Global Buying Green Report, by Trivium Packaging a high-quality and infinitely recyclable metal packaging provider based in the Netherlands, conduct a survey of end users in Europe, North America, and South America found that 86% of younger generations consumers were willing to pay more for sustainable packaging.
However, as many governments all around the world are aware of threats associated with environmental issues, several policies have been implemented to encourage eco-friendly packaging manufacturers. Favorable government policies allowing subsidies to packaging manufacturers, particularly in developed nations, create lucrative opportunities for market players to increase their production volume. Under the pressure of these government initiatives, major players have started investing in expanding numerous recycling programs for waste packaging materials released from various commercial units and industries. Many market players have focused their efforts on generating innovative technologies for shifting to environmentally friendly packaging solutions for food packaging to reduce environmental impact.
Along with this, merger, and acquisition activity in the packaging market enhances companies' presence in the global scale as these acquisitions help companies to better serve their customers and meet the growing demand for sustainable pharmaceutical packaging in the forecasted period. In 2021, SCHOTT and Serum Institute of India announced joint venture for pharmaceutical packaging in various products such as vials, syringes, ampoules and cartridges that are used to package life-saving medications. The high cost of sustainability packaging due to the high cost of recycling processing of packaging materials and fluctuation in the price of raw materials limiting the market growth during the forecast period. Along with this, availability of low-cost alternative solutions such as paper bubble wrap, paper tape, and corn starch packaging, is restraining the growth of the Global Sustainable Pharmaceutical Packaging Market.
Key Market Challenges
Research & Development Expenditure
Research and development (R&D) expenditure can have a dual impact on the demand for sustainable pharmaceutical packaging globally. On one hand, pharmaceutical companies invest significant resources into R&D efforts to develop innovative medications and therapies, often prioritizing advancements in drug efficacy, safety, and regulatory compliance. As a result, R&D budgets may be heavily allocated towards drug development rather than sustainable packaging solutions. This can lead to limited investment in researching and implementing sustainable packaging materials and technologies, potentially decreasing the availability and adoption of eco-friendly packaging options in the pharmaceutical industry.
On the other hand, some pharmaceutical companies recognize the importance of sustainability and allocate a portion of their R&D budget towards developing sustainable packaging alternatives. However, the overall impact of R&D expenditure on the demand for sustainable pharmaceutical packaging globally ultimately depends on the priorities and strategies of individual pharmaceutical companies and the regulatory landscape within which they operate.
Material Innovation Constraints
Material innovation constraints are posing challenges and decreasing the demand for sustainable pharmaceutical packaging globally. While there is growing interest and awareness in adopting eco-friendly packaging solutions within the pharmaceutical industry, the availability of suitable materials for sustainable packaging remains limited. Constraints in material innovation, such as the development of biodegradable polymers with the necessary properties for pharmaceutical packaging, can hinder progress in adopting sustainable packaging alternatives. Ensuring that sustainable materials meet stringent regulatory requirements for pharmaceutical packaging, including compatibility with drug formulations, stability, and shelf-life considerations, further complicates the adoption process.
The high cost of developing and scaling up production of novel sustainable materials may deter pharmaceutical companies from investing in sustainable packaging solutions. As a result, material innovation constraints continue to impede the widespread adoption of sustainable pharmaceutical packaging, highlighting the need for collaborative efforts among stakeholders to overcome these challenges and drive innovation in eco-friendly packaging materials and technologies.
Key Market Trends
Innovations in Biodegradable Materials
Innovations in biodegradable materials are fueling an increase in the demand for sustainable pharmaceutical packaging globally. Traditional pharmaceutical packaging, often composed of plastic or non-biodegradable materials, contributes to environmental pollution and waste accumulation. However, the development of biodegradable alternatives offers a more eco-friendly solution to packaging pharmaceutical products. Biodegradable materials, derived from renewable sources such as plant-based polymers or bioplastics, have gained traction due to their ability to break down naturally into non-toxic components, reducing environmental impact and landfill waste.
Advancements in biodegradable packaging technologies have led to the creation of innovative packaging solutions that maintain product integrity, safety, and shelf-life while minimizing environmental harm. As awareness of environmental sustainability grows among consumers, pharmaceutical companies are increasingly prioritizing the adoption of sustainable packaging practices to meet consumer demands and reduce their carbon footprint. Consequently, the demand for sustainable pharmaceutical packaging, driven by innovations in biodegradable materials, is on the rise globally, reshaping the pharmaceutical industry's approach to packaging and sustainability.
Expansion of Pharmaceutical Markets
The expansion of pharmaceutical markets globally is driving an increased demand for sustainable pharmaceutical packaging. As pharmaceutical companies expand their reach into new markets and regions, the volume of pharmaceutical products being produced and distributed is growing exponentially. This surge in production translates to a corresponding increase in the demand for packaging materials to ensure the safe and efficient delivery of medications to consumers.
However, with growing concerns over environmental sustainability and plastic pollution, there is a growing preference for sustainable packaging options among consumers, regulatory agencies, and pharmaceutical companies alike. Sustainable pharmaceutical packaging, which encompasses biodegradable, recyclable, and environmentally friendly materials, is becoming increasingly sought after as a means to reduce the environmental impact of pharmaceutical products throughout their lifecycle. As a result, the expansion of pharmaceutical markets is fueling a growing demand for sustainable packaging solutions globally, driving innovation and investment in eco-friendly packaging materials and technologies across the pharmaceutical industry.
Segmental Insights
Material Insights
Based on the Material, within the Global Sustainable Pharmaceutical Packaging Market, it is commonly observed that plastic, due to its versatility and cost-effectiveness, has a substantial share. However, there is an increasing push toward glass and metal packaging solutions owing to their recyclability and reduced environmental footprint. Glass, in particular, is gaining favor for its inert nature, which is crucial for preserving the integrity of sensitive pharmaceutical formulations. Its ability to maintain the quality and stability of medications over extended periods is highly valued in the industry. Metal packaging options are also gaining traction due to their durability and ability to provide enhanced protection against external factors. Despite the growing popularity of glass and metal, plastic remains a dominant player due to ongoing innovations in biodegradable and recyclable polymers. These advancements contribute to the sustainability efforts of the pharmaceutical industry by reducing the environmental impact of plastic packaging. As the industry continues to evolve, a balance between the use of different materials will be crucial in ensuring the sustainability and effectiveness of pharmaceutical packaging solutions.
Process Insights
Based on the Process segment, among various eco-friendly packaging solutions, biodegradable packaging is currently witnessing significant growth within the Global Sustainable Pharmaceutical Packaging Market. This surge is driven by a heightened awareness of environmental issues and the implementation of stringent regulations aimed at reducing packaging waste. Biodegradable materials, which are specifically designed to decompose naturally, offer a sustainable solution with minimal environmental impact. This makes them an increasingly popular choice for companies seeking to enhance their sustainability credentials and reduce their carbon footprint. As ongoing research and development efforts continue to improve the durability and protective qualities of biodegradable packaging, its prominence in the pharmaceutical industry is expected to grow even further, leading to a more sustainable and environmentally conscious future for the sector.
Regional Insights
Europe is widely recognized as a frontrunner in the Global Sustainable Pharmaceutical Packaging Market. This position is largely attributed to the region's implementation of stringent regulations focused on reducing packaging waste and its strong cultural emphasis on sustainability. The commitment to environmental protection in Europe is further bolstered by the active participation of numerous leading pharmaceutical companies that are dedicated to adopting sustainable practices. As a result, Europe has emerged as a dominant player in this sector, driving innovation and setting new standards for sustainable pharmaceutical packaging worldwide. The European Union, in particular, has been at the forefront of promoting sustainable packaging solutions in the pharmaceutical industry. Through its comprehensive regulatory framework, which includes directives on waste management, recycling, and eco-design, the EU has created a conducive environment for the development and adoption of sustainable packaging practices. This approach not only ensures the reduction of packaging waste but also promotes the use of eco-friendly materials and designs that minimize the environmental impact.
Europe's strong cultural emphasis on sustainability plays a significant role in driving the demand for sustainable pharmaceutical packaging. Consumers in the region are increasingly conscious of the environmental impact of their choices and are actively seeking out products that align with their values. This shift in consumer preferences has compelled pharmaceutical companies to prioritize sustainability in their packaging strategies, leading to the adoption of innovative and eco-friendly solutions.
Recent Developments
- In February 2023, Gerresheimer AG, announced its collaboration with Corning Incorporated. This joint venture aims to expand the global availability of the Velocity Vial technology platform, which addresses the demand for an efficient and economical process for filling injectable drugs with high quality.
- In January
2023, West Pharmaceutical Services, Inc. announced its participation at
Pharmapack Europe 2023 in Paris, France. The company demonstrated its
leadership and expertise in addressing industry challenges and trends in
packaging and containment. As part of its commitment to serving global
customers and their patients, West Pharmaceutical Services introduced three new
productsthe West Ready Pack featuring Corning Valor RTU Vials utilizing
Stevanato Group's EZ-fill SG EZ-fill technology, the Daikyo Crystal Zenith 2.25mL Insert Needle Syringe System, and the FluroTec 5-10mL Cartridge
Plunger.
Key Market Players
- Amcor plc
- WestRock Company
- Schott AG
- Sonoco Products Company
- Berry Global Group, Inc.
- Mondi plc
- Smurfit Kappa Group plc
- Sealed Air Corporation
- DS Smith Plc
- Körber AG
|
By Material |
By Process |
By Product Type |
By End User |
By Region |
||
|
|
|
|
|
|
|
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy